Treatment results of the TPOG-NHL92 protocols for childhood non-Hodgkin's lymphomas in Taiwan: A report from the Taiwan Pediatric Oncology Group (TPOG)

Acta Paediatrica Taiwanica

Volumn 41, Issue 4, 2000, Pages 193-204

  Yang, C P ^a   Hung, I J ^a   Jaing, T H ^a   Lin, K H ^a   Lin, D T ^a   Lu, M Y ^a   Liang, D C ^a   Chen, S H ^a   Liu, H C ^a   Hsiao, C C ^a   Shu, S G ^a   Chen, J S ^a   Chang, T T ^a   Chiou, S S ^a   Hsieh, Y L ^a   Lin, M T ^a   Lee, M T ^a   Peng, C T ^a   Cheng, S N ^a   Chen, R L ^a   Chen, B W ^a   Lin, K S ^a   more..

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Chemotherapy; Childhood; Non Hodgkin's lymphoma; Treatment results

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; ETOPOSIDE; FOLINATE CALCIUM; HYDROCORTISONE; LOMUSTINE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PROGNOSIS; TAIWAN; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM STAGING;

EID: 0033821132     PISSN: 00016578     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Malignant neoplasms in children: Analysis of 642 cases
2. A morphologic study of childhood lymphoma of the lymphoblastic type: The Pediatric Oncology Group experience
3. Studies on the pathology of non-Hodgkin's lymphoma of childhood: The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study Group
4. The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma. Summary and description of a working formulation for clinical usage
5. Therapy of localized and regional lymphosarcoma of childhood
6. Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy
7. 2)
8. Malignant non-Hodgkin's lymphoma in children
9. Non-Hodgkin's lymphoma in children
10. The treatment of localized non-Hodgkin's lymphoma in children: A report from the Children's Cancer Study Group
11. End results of treating children with localized non-Hodgkin's lymphomas with a combined modality approach of lessened intensity
12. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: A report from the Children's Cancer Study Group
13. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy
14. 2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded)
15. 2 with the A-COP+ therapeutic regimen. A Pediatric Oncology Group study
16. BFM trials for childhood non-Hodgkin's lymphomas
17. A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: Early and intermittent use of teniposide plus cytarabine
18. Treatment of advanced stage T cell lymphoblastic lymphoma: Results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503
19. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia
20. 2 protocol with high-dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma
21. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society
22. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: Results of a Pediatric Oncology Group study
23. Results of treatment of advanced-stage Burkitt's lymphoma and B-cell (Slg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine
24. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM Group
25. High survival rate in advanced-stage B cell lymphomas and leukemias without CNS involvement with short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children
26. High survival rate of childhood B-cell lymphoma and leukemia (ALL) as result of the LMB 89 protocol of the SFOP (French Pediatric Oncology Society)
27. APO therapy for malignant lymphoma of large cell 'histiocytic' type of childhood. Analysis of treatment results for 29 patients
28. Nonlymphoblastic lymphoma in children - Histology and stage-related response to therapy: A Pediatric Oncology Group study
29. Childhood non-Hodgkin's lymphoma
30. Outcome of advanced stage (III-IV) lymphoblastic non Hodgkin's lymphoma-a Pediatric Oncology Group (POG) study
31. Results of LMB 86 and LMB 89 protocols of the French Pediatric Oncology Society (S.F.O.P.) for children with B-cell lymphoma and leukemia with CNS involvement (CNS+)
32. Nonparametric estimation from incomplete observations
33. Evaluation of survival data and two new rank order statistics arising in its consideration
34. Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage-a report of the Berlin-Frankfurt-Munster Group
35. Non-Hodgkin's lymphomas of childhood: An analysis of the histology, staging, and response to treatment of 338 cases at a single institution
36. Treatment of children with localized non-Hodgkin's lymphoma (NHL) with nine weeks of chemotherapy without radiotherapy
37. 2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Children's Cancer Group
38. Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies
39. Treatment of childhood lymphoblastic lymphomas. Results of the SFOP LMT 89 protocol (French Pediatric Oncology Society)
40. Risk-adapted therapy for lymphoblastic T-cell lymphoma: Results from trials NHL-BFM 86 and 90
41. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia
42. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group